Summary & Overview
CPT 88184: Flow Cytometry Technical Component, First Marker
CPT code 88184 represents the technical component of a flow cytometry test using a single cell surface, cytoplasmic, or nuclear marker to characterize cells. This laboratory service is used to support diagnosis and monitoring of diseases such as blood cancers and immune disorders. As a widely used laboratory procedure, accurate coding of 88184 affects clinical reporting, claims processing, and national utilization patterns for laboratory medicine.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical role, typical sites of service, and the payer landscape relevant to coverage and billing practice. The publication outlines common modifiers and operational considerations for reporting the technical component for the first marker, and highlights related procedural context for laboratory administrators and billing staff.
This summary provides national-level context on why 88184 matters: it standardizes reporting for an essential diagnostic laboratory function, influences reimbursement workflows, and supports downstream clinical decision-making in oncology and immunology. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 88184 describes the technical component of a flow cytometry procedure that uses a cell surface, cytoplasmic, or nuclear marker to characterize cells. The lab analyst performs laboratory processing and data acquisition for the first marker included in the procedure. This service supports clinical diagnosis and monitoring of conditions such as hematologic malignancies and immune dysfunctions.
Service type: Laboratory — flow cytometry, technical component
Typical site of service: Clinical laboratory or hospital-based laboratory
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with unexplained persistent lymphadenopathy and cytopenias is referred to hematology-oncology. The clinician orders flow cytometry to characterize peripheral blood and bone marrow aspirate cells using cell surface markers to evaluate for suspected non-Hodgkin lymphoma or leukemia. A phlebotomy or bone marrow collection is performed; specimens are sent to the clinical laboratory. The laboratory analyst performs the technical component of flow cytometry, preparing specimens, running cells through the flow cytometer, staining with the initial fluorescently labeled antibody marker, acquiring and gating data, and generating instrument files and preliminary technical observations. Results are reported to the ordering clinician, who integrates flow cytometry findings with morphology and cytogenetics to establish diagnosis and direct treatment planning. The procedure billed under 88184 reflects the technical work for the first marker in a single- or multi-color panel; additional markers are billed separately when applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation of a test when split billing applies and the laboratory reports the professional component separately. |